Annual report pursuant to Section 13 and 15(d)

CollabRx Acquisition (Tables)

v2.4.0.8
CollabRx Acquisition (Tables)
 12 Months Ended
Mar. 31, 2014
CollabRx Acquisition [Abstract]  
Purchase Price Allocation for Acquisition of CollabRx
The purchase price for the CollabRx acquisition was allocated as follows:

PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX
 
Assets acquired:
  
 
Developed Technology
  
$
720
  
Customer Relationships
    
433
  
Trade Name
    
346
  
Non Compete Agreement
    
151
  
Cash
    
476
  
AP and accrueds
    
(333
)
Deferred tax liability
    
(664
)
Goodwill
    
603
  
Total Acquired Assets, net
  
$
1,732
  
 
        
 
        
 
        
Purchase Price summary:
        
Common Stock Consideration
  
$
932
  
Promissory Note Assumed
    
500
  
Loan/Note Payable Assumed
    
300
  
 
  
$
1,732